Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
Published:
Last Updated:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive
compensation for actions taken through them.
The short interest data are out for the July 29 settlement date. Companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big potential downside. In fact, a cure or incredible new breakthrough in cancer or Alzheimer’s disease will be worth more than any risks from Brexit or political rhetoric from the campaign trail.
FDA rulings can make or break the biotech sector, and short sellers and mega-bulls often go to war against each other in these companies. After all, if a single failed clinical trial can mean disaster for a stock, then some short sellers can argue for a stock implosion down the road.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The July 29 short interest data have been compared with the previous report, and short interest decreased across these selected biotech stocks.
Amgen Inc. (NASDAQ: AMGN) saw its short interest decrease to 7.61 million shares from the previous level of 7.82 million. Shares closed most recently at $172.08, in a 52-week trading range of $130.09 to $176.50.
Biogen Inc. (NASDAQ: BIIB) had its short interest retreat slightly to 2.56 million shares from the previous 2.58 million. The stock closed Tuesday at $314.42, within a 52-week range of $223.02 to $333.65.
Celgene Corp. (NASDAQ: CELG) short interest for this settlement date decreased to 5.87 million shares from the previous 7.13 million. Shares closed most recently at $113.80, in a 52-week range of $92.98 to $132.60.
Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest decline to 20.82 million shares from 21.41 million in the previous period. Shares closed Tuesday at $79.31, in a 52-week trading range of $77.92 to $117.70.
MannKind Corp. (NASDAQ: MNKD) saw its short interest pull back to 83.29 million shares. The previous reading was 86.15 million. Shares closed most recently at $0.92, in a 52-week trading range of $0.64 to $4.46.
Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) short interest fall to 5.73 million, compared to the previous level of 6.35 million. Shares closed most recently at $135.00, in a 52-week range of $110.56 to $193.45.
Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Get started right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.